Transfusion medicine: looking to the future (Q35047211)

6 August 2017

1 reference

title

Transfusion medicine: looking to the future (English)

1 reference

6 August 2017

Lawrence T Goodnough

1

1 reference

6 August 2017

Aryeh Shander

series ordinal

2

1 reference

6 August 2017

Mark E Brecher

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

361

1 reference

6 August 2017

9352

1 reference

6 August 2017

161-169

1 reference

Blood and disaster--supply and demand

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Earthquake in America

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Transfusion medicine. First of two parts--blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

A multicenter study of in vitro and in vivo values in human RBCs frozen with 40-percent (wt/vol) glycerol and stored after deglycerolization for 15 days at 4 degrees C in AS-3: assessment of RBC processing in the ACP 215.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Safety of the blood supply in the United States: opportunities and controversies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

The first case of HCV seroconversion after 3 years of HCV NAT screening in Baden-Württemberg

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

A retrospective analysis of microbial contaminants in outdated random-donor platelets from multiple sites

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Don't bug me: the problem of bacterial contamination of blood components--challenges and solutions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Single-donor platelets reduce the risk of septic platelet transfusion reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Evaluation of an automated culture system for detecting bacterial contamination of platelets: an analysis with 15 contaminating organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Growth of bacteria in inoculated platelets: implications for bacteria detection and the extension of platelet storage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Reassessment of blood donor selection criteria for United States travelers to malarious areas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Transfusion Malaria in the United States, 1972-1981

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Transfusion-transmitted malaria in the United States from 1963 through 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Safety of blood supply for infectious diseases in Latin American countries, 1994-1997

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Specific antibodies to Trypanosoma cruzi among blood donors in Los Angeles, California

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Transmission of tick-borne agents of disease by blood transfusion: a review of known and potential risks in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

"Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Creutzfeldt-Jakob disease and transfusion safety: tilting at icebergs?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Transfusion errors in New York State: an analysis of 10 years' experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Reports of 355 transfusion-associated deaths: 1976 through 1985.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Autologous donation error rates in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Is it time for blood banking to take off?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Reporting of near-miss events for transfusion medicine: improving transfusion safety

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Improvement in transfusion safety using a new blood unit and patient identification system as part of safe transfusion practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

An automated system for bedside verification of the match between patient identification and blood unit identification

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Reversal of Left Ventricular Hypertrophy Following Recombinant Human Erythropoietin Treatment of Anaemic Dialysed Uraemic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Effect of anaemia and cardiovascular disease on surgical mortality and morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Blood Transfusion in Elderly Patients with Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Anemia, transfusion, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Transfusion practice should be audited for both undertransfusion and overtransfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Is undertransfusion occurring?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Transfusion medicine. Second of two parts--blood conservation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Potential role for rFVIIa in transfusion medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Blood substitutes — a moving target

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Progress in the development of RBC substitutes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Recombinant human hemoglobin (rHb1.1) selectively inhibits vasorelaxation elicited by nitric oxide donors in rabbit isolated aortic rings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

1 reference

7 January 2021

Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Use of Oxygent, a perfluorochemical-based oxygen carrier, as an alternative to intraoperative blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Perflubron emulsion delays blood transfusions in orthopedic surgery. European Perflubron Emulsion Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Red blood cell substitutes: current status.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Bioartificial organ support for hepatic, renal, and hematologic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Cardiovascular and coronary physiology of acute isovolemic hemodilution: a review of nonoxygen-carrying and oxygen-carrying solutions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Blood substitute and erythropoietin therapy in a severely injured Jehovah's witness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

The value of oxygen-carrying solutions in the operative setting, as determined by mathematical modeling.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Transfusions of polymerized bovine hemoglobin in a patient with severe autoimmune hemolytic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG): multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Therapeutic plasma exchange: an update from the Canadian Apheresis Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Partial amino acid sequence of purified von Willebrand factor-cleaving protease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

What is a transfusion medicine specialist?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912195-2

7 January 2021

10.1016/S0140-6736(03)12195-2

Identifiers

DOI

1 reference

6 August 2017

1 reference